Global Contraceptive Drugs & Devices Market Report 2018-2023: Market to Grow at a CAGR of 7.5% - ResearchAndMarkets.com

DUBLIN--()--The "Global Contraceptive Drugs and Devices Market - Segmented by Contraceptive Method, by Mode of Delivery, by Type of Device, by Gender and Geography - Growth, Trends and Forecasts (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Contraceptive Drugs and Devices Market is projected to grow at a CAGR of 7.5% during the forecast period (2018-2023). China being the world's most-populated country has a population count of about 1.36 billion and has one of the highest rate of contraceptives usage.

Not using of the contraceptives or the incorrect use of the contraceptives may result in unintended pregnancies and the number of unintended pregnancies percentage is higher in the teens younger than 18 years, followed by the age group of 20-24 years.

In the United States, the proportion of pregnancies that were unintended increased slightly between 2001 and 2008 (from 48% to 51%), but, by 2011 it decreased to 45%. And in 2014, these contraceptives have helped women to avoid 2 million unintended pregnancies, which would likely have resulted in 900,000 unplanned births and nearly 700,000 abortions. However, over past few years the awareness on contraception has contributed to both decline in unplanned pregnancies and also growth in the usage of the contraceptives market.

There are also other factors which are accelerating the growth of the contraceptives market is the increasing incidence of the STDs and the rapid increase in the population.

The government initiatives are also promoting the use of contraceptives to avoid the unnecessary births and the health benefits from using the contraceptives have also been significant players in the growth of this market.

In North America, over 90% of the female population uses the modern contraceptive techniques. The use of contraceptives is the highest in North America, whose share is estimated to be 75.4%. Following North America, Europe is the second largest market globally and the preference of the contraceptives generally varies by region.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Bayer Healthcare
  • Pfizer
  • Merck & Co.
  • Teva Pharmaceuticals Ltd.
  • Agile Therapeutics
  • Actavis PLC
  • ANI Pharmaceuticals Inc.
  • Church & Dwight Co. Inc.
  • Fuji Latex Co. Ltd
  • Johnson & Johnson Ltd.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/gzmgzm/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health